Učitavanje...
The expanding role of pertuzumab in the treatment of HER2-positive breast cancer
Breast cancer tumors that demonstrate gene amplification or overexpression of human epidermal growth factor receptor 2 (HER2) are classified as HER2-positive. They account for approximately 15% of all breast cancers and represent an adverse prognostic factor. Over the past years, many new therapies...
Spremljeno u:
| Izdano u: | Breast Cancer (Dove Med Press) |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4445592/ https://ncbi.nlm.nih.gov/pubmed/26056489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S61579 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|